Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04065269
Title ATr Inhibitor in Combination With Olaparib in Gynaecological Cancers With ARId1A Loss or no Loss (ATARI)
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Institute of Cancer Research, United Kingdom
Indications

endometrial clear cell adenocarcinoma

cervical adenocarcinoma

endometrial carcinoma

ovarian clear cell adenocarcinoma

carcinosarcoma

cervical squamous cell carcinoma

Therapies

Ceralasertib + Olaparib

Ceralasertib

Age Groups: adult | senior
Covered Countries


No variant requirements are available.